Balyasny Asset Management LLC Fulgent Genetics, Inc. Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$21.55 - $29.29 $236,920 - $322,014	10,994 New	10,994 $238,000
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $245,528 - $350,386	8,609 New	8,609 $318,000
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $594,333 - $819,013	-20,333 Reduced 59.74%	13,700 $407,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $50,471 - $84,837	1,331 Added 4.07%	34,033 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $1.57 Million - $2.05 Million	32,702 New	32,702 $1.78 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $228,962 - $311,010	-2,962 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$74.87 - $110.87 $221,764 - $328,396	2,962 New	2,962 $266,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.